TP53 and ovarian carcinoma: Although it has been suggested that S1P, a ligand for S1PR1, is aberrantly produced in ovarian cancer patients and that p53 is mutated in most ovarian cancer patients, little is known about the interaction between S1PR1 and the mutant p53 in ovarian cancer.